A Randomized, Double-blind, Parallel-Controlled Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants
Phase of Trial: Phase III
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Pneumococcal 13 valent vaccine conjugate-Beijing-Minhai-Biotechnology (Primary) ; Pneumococcal 7-valent CRM197 vaccine conjugate
- Indications Pneumococcal infections
- Focus Pharmacodynamics; Registrational
- 31 Aug 2016 Planned End Date changed from 1 Oct 2016 to 1 Dec 2017.
- 31 Aug 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Dec 2017.
- 31 Aug 2016 Status changed from not yet recruiting to recruiting.